Abstract
Neuroinflammation is the local reaction of the brain to infection, trauma, toxic molecules or protein aggregates. The brain resident macrophages, microglia, are able to trigger an appropriate response involving secretion of cytokines and chemokines, resulting in the activation of astrocytes and recruitment of peripheral immune cells. IL-1β plays an important role in this response; yet its production and mode of action in the brain are not fully understood and its precise implication in neurodegenerative diseases needs further characterization. Our results indicate that the capacity to form a functional NLRP3 inflammasome and secretion of IL-1β is limited to the microglial compartment in the mouse brain. We were not able to observe IL-1β secretion from astrocytes, nor do they express all NLRP3 inflammasome components. Microglia were able to produce IL-1β in response to different classical inflammasome activators, such as ATP, Nigericin or Alum. Similarly, microglia secreted IL-18 and IL-1α, two other inflammasome-linked pro-inflammatory factors. Cell stimulation with α-synuclein, a neurodegenerative disease-related peptide, did not result in the release of active IL-1β by microglia, despite a weak pro-inflammatory effect. Amyloid-β peptides were able to activate the NLRP3 inflammasome in microglia and IL-1β secretion occurred in a P2X7 receptor-independent manner. Thus microglia-dependent inflammasome activation can play an important role in the brain and especially in neuroinflammatory conditions.
Highlights
Inflammatory processes have been implicated in both acute and chronic neurodegenerative conditions
IL-1β production has been linked to neuroinflammatory conditions and neurodegenerative diseases for a long time with both beneficial and detrimental effects described
We aimed to characterize in more detail the in vitro capacities of microglia and astrocytes separately to respond to inflammasome activation, since this issue has not clearly been addressed
Summary
Inflammatory processes have been implicated in both acute and chronic neurodegenerative conditions. Pro-inflammatory cytokine production has been associated with neuroinflammation and different neurodegenerative diseases, such as Alzheimer’s disease (AD), Parkinson’s disease (PD) and Multiple Sclerosis (MS) [1,2,3]. Inflammation may not typically represent an initiating factor in neurodegenerative diseases, there is emerging evidence in animal models that sustained inflammatory responses involving microglia and astrocytes contribute to PLOS ONE | DOI:10.1371/journal.pone.0130624. Inflammation may not typically represent an initiating factor in neurodegenerative diseases, there is emerging evidence in animal models that sustained inflammatory responses involving microglia and astrocytes contribute to PLOS ONE | DOI:10.1371/journal.pone.0130624 June 19, 2015
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have